These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16823773)

  • 1. Prevention of farnesylation of c-Ha-Ras protein enhances synergistically the cytotoxic action of doxorubicin in cycling but not in quiescent cells.
    Wesierska-Gadek J; Kramer M; Schmid G
    J Cell Biochem; 2006 Dec; 99(6):1664-76. PubMed ID: 16823773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
    Schmid G; Kramer MP; Wesierska-Gadek J
    J Cell Physiol; 2009 May; 219(2):459-69. PubMed ID: 19170070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined treatment of HeLa cells with the farnesyl protein transferase inhibitor L-744,832 and cisplatin significantly increases the therapeutic effect as compared to cisplatin monotherapy.
    Wesierska-Gadek J; Kramer MP; Schmid G
    J Cell Biochem; 2008 May; 104(1):189-201. PubMed ID: 18022825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
    Matesic DF; Villio KN; Folse SL; Garcia EL; Cutler SJ; Cutler HG
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):741-54. PubMed ID: 16254733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin.
    Chen X; Hasuma T; Yano Y; Yoshimata T; Morishima Y; Wang Y; Otani S
    Anticancer Res; 1997; 17(4A):2555-64. PubMed ID: 9252680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras farnesyltransferase inhibition: a novel and safe approach for cancer chemotherapy.
    Nammi S; Lodagala DS
    Acta Pharmacol Sin; 2000 May; 21(5):396-404. PubMed ID: 11324435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible inactivation of the transcriptional function of P53 protein by farnesylation.
    Couderc B; Penary M; Tohfe M; Pradines A; Casteignau A; Berg D; Favre G
    BMC Biotechnol; 2006 May; 6():26. PubMed ID: 16732889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeranyl as well as farnesyl moiety is transferred to Ras p21 overproduced in adrenocortical cells transformed by c-Ha-rasEJ oncogene.
    Osman H; Mazet JL; Maume G; Maume BF
    Biochem Biophys Res Commun; 1997 Feb; 231(3):789-92. PubMed ID: 9070894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the mitogenic signal from an oncogene ras protein.
    Durkin JP; Whitfield JF
    Anticancer Res; 1989; 9(5):1313-23. PubMed ID: 2686532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.
    Sepp-Lorenzino L; Tjaden G; Moasser MM; Timaul N; Ma Z; Kohl NE; Gibbs JB; Oliff A; Rosen N; Scher HI
    Prostate Cancer Prostatic Dis; 2001; 4(1):33-43. PubMed ID: 12497061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
    Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of proliferation of HeLa cells by the alpha-fetoprotein.
    Li MS; Li PF; Li G; Du GG
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):769-74. PubMed ID: 12417922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint.
    Wesierska-Gadek J; Schmid G
    J Cell Biochem; 2000 Sep; 80(1):85-103. PubMed ID: 11029756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
    Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
    Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest.
    Wesierska-Gadek J; Maurer M; Schmid G
    J Cell Biochem; 2007 Oct; 102(3):736-47. PubMed ID: 17415788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of farnesyl-protein-transferase in neuroblastoma cells by alpha-hydroxyfarnesylphosphonate.
    Girgert R; Hohnecker A; Wittrock J; Schweizer P
    Anticancer Res; 1999; 19(4B):2959-62. PubMed ID: 10652579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of 2,6-di(2,3-epoxypropoxy)xanthone on tumor cell lines.
    Liu HS; Lin CN; Won SJ
    Anticancer Res; 1997; 17(2A):1107-14. PubMed ID: 9137457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of amyloid precursor protein in HEK cells alters p53 conformational state and protects against doxorubicin.
    Uberti D; Cenini G; Olivari L; Ferrari-Toninelli G; Porrello E; Cecchi C; Pensalfini A; Liguri G; Govoni S; Racchi M; Maurizio M
    J Neurochem; 2007 Oct; 103(1):322-33. PubMed ID: 17608641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.